1. Home
  2. INTZ vs CVKD Comparison

INTZ vs CVKD Comparison

Compare INTZ & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intrusion Inc.

INTZ

Intrusion Inc.

HOLD

Current Price

$1.05

Market Cap

18.9M

ML Signal

HOLD

Logo Cadrenal Therapeutics Inc.

CVKD

Cadrenal Therapeutics Inc.

HOLD

Current Price

$7.83

Market Cap

19.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTZ
CVKD
Founded
1983
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
19.0M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
INTZ
CVKD
Price
$1.05
$7.83
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$7.25
$32.00
AVG Volume (30 Days)
139.4K
50.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
85.78
N/A
EPS
N/A
N/A
Revenue
$5,771,000.00
N/A
Revenue This Year
$35.44
N/A
Revenue Next Year
$23.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.85
N/A
52 Week Low
$0.75
$4.91
52 Week High
$2.64
$20.39

Technical Indicators

Market Signals
Indicator
INTZ
CVKD
Relative Strength Index (RSI) 51.44 57.50
Support Level $0.86 $6.64
Resistance Level $1.15 $8.79
Average True Range (ATR) 0.10 0.73
MACD 0.03 0.20
Stochastic Oscillator 68.11 78.52

Price Performance

Historical Comparison
INTZ
CVKD

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: